Grail, Inc. (NASDAQ:GRAL) President Sells $65,800.80 in Stock

Grail, Inc. (NASDAQ:GRAL) President Joshua J. Ofman sold 2,109 shares of the business’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $65,800.80. Following the transaction, the president now directly owns 559,673 shares in the company, valued at approximately $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Grail Stock Down 12.7 %

GRAL opened at $26.92 on Friday. The firm’s fifty day moving average price is $31.60 and its 200 day moving average price is $21.19. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99.

Grail (NASDAQ:GRAL) last posted its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. As a group, research analysts predict that Grail, Inc. will post -15.15 EPS for the current year.

Institutional Trading of Grail

Several institutional investors have recently added to or reduced their stakes in GRAL. FNY Investment Advisers LLC acquired a new stake in Grail in the fourth quarter valued at $26,000. Lindbrook Capital LLC bought a new stake in Grail during the fourth quarter valued at $28,000. State of Tennessee Department of Treasury bought a new stake in Grail during the fourth quarter valued at $28,000. Sterling Capital Management LLC bought a new stake in Grail during the fourth quarter valued at $29,000. Finally, Wellington Shields Capital Management LLC bought a new stake in Grail during the fourth quarter valued at $33,000.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on GRAL. Wolfe Research began coverage on shares of Grail in a research report on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley started coverage on shares of Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.